Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period

2005/08/01 by Raúl J. Andrade, R ANDRADE, M. Isabel Lucena +17 · 31 citations
Pharmacology, Toxicology and Pharmaceutics · Medicine · #Drug-Induced Hepatotoxicity and Protection #Poisoning and overdose treatments #Drug Transport and Resistance Mechanisms

paper · pdf · doi:10.1016/j.gastro.2005.05.006

Citations

• Acute Liver Injury Associated With Nonsteroidal Anti-inflammatory Drugs and the Role of Risk Factors
• Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

Cited by

• Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
• Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States
• Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury
• Beyond Hy's Law: Importance of Markedly Elevated Aminotransferases without Hyperbilirubinemia
• Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases
• Clinical and Genetic Associations in Cephalosporin‐Induced Liver Injury: Insights From the Drug‐Induced Liver Injury Network
• Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China. [europepmc]
• Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps. [europepmc]
• Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease. [europepmc]
• Drug-Induced Liver Injury: Pattern Recognition and Future Directions. [europepmc]
• RUCAM in Drug and Herb Induced Liver Injury: The Update. [europepmc]
• Hepatotoxicity by Drugs: The Most Common Implicated Agents. [europepmc]
• The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative. [europepmc]
• Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States. [europepmc]
• Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics. [europepmc]
• Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury. [europepmc]
• Oxidative Stress and Liver Morphology in Experimental Cyclosporine A-Induced Hepatotoxicity. [europepmc]
• Research Advances on Hepatotoxicity of Herbal Medicines in China. [europepmc]
• Drug-induced liver injury: recent advances in diagnosis and risk assessment. [europepmc]
• Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis. [europepmc]
• A nationwide study of the incidence rate of herb-induced liver injury in Korea. [europepmc]
• Mechanism Investigation of Rifampicin-Induced Liver Injury Using Comparative Toxicoproteomics in Mice. [europepmc]
• Drug-induced cholestasis. [europepmc]
• Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury. [europepmc]
• Herb-Induced Liver Injuries in Developing Nations: An Update. [europepmc]
• Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives. [europepmc]
• Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010-2019). [europepmc]
• Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis. [europepmc]
• Superoxide Dismutase Administration: A Review of Proposed Human Uses. [europepmc]
• A revised electronic version of RUCAM for the diagnosis of DILI. [europepmc]
• Drug-induced liver injury: a comprehensive review. [europepmc]